EMMPRIN Expression Is Required for Response to Bevacizumab Therapy in HNSCC Xenografts

Cancer Letters - Ireland
doi 10.1016/j.canlet.2008.09.033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search